J&J Tamps Down M&A Ambitions

July 19, 2022

Johnson & Johnson’s new CEO Joaquin Duato has repeatedly told analysts and investors that the company was going to pursue an aggressive M&A campaign. In a call earlier today, July 19th, Duato signalled a shift and toned down those ambitions as the company’s expected 2022 sales growth dropped from 4-5% to 3%. However, this does not mean that J&J has completely written off any acquisitions.

According to Paul Schloesser, “Highlighting J&J’s current M&A strategy under his leadership, the CEO said that the first thing the company will try to look at is room for improvement in standard of care for a specific opportunity — ultimately remaining agnostic about which opportunity is open — and beyond that, try to push into higher growth markets for a “fair financial return.””

To read more, click here.